{'fraction_non_alphanumeric': 0.01765650080256822, 'fraction_numerical': 0.0, 'mean_word_length': 5.5, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Duration of treatment for Lyme borreliosis: time for a critical reappraisal.

Over time the recommended duration of antibiotic therapy for patients with erythema migrans has increased. This change in prescribing practice is not evidence-based. The presumptions that post-treatment subjective complaints, which occur in a minority of patients, may be reduced by increasing the duration of initial therapy or ameliorated by a repeat course of parenteral or oral antimicrobials, have not been supported by recent clinical trials. Recommendations on duration of treatment of early Lyme borreliosis deserve critical reappraisal.